Cannabis Law Report

JUNE 9, 2022

The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. “; 6) Article 15 shall be worded as follows: “Article 15. 532) with the following paragraph 156: «.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

The Cannigma

FEBRUARY 11, 2021

All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I And I had been a serious chronic pain patient, plus some other issues after having spinal meningitis back in 1996. Elana: So you mentioned the three factors for compliance. I know how to collect data.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

SEPTEMBER 23, 2019

The AAFP advocates for robust regulation regarding labeling and child-proof packaging of all marijuana and cannabinoid products. Cannabinoids have been assessed for chronic pain management. Several studies indicate smoked THC and nabiximols were both associated with pain reduction.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40